VistaGen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · IEX Real-Time Price · USD
3.660
-0.040 (-1.08%)
At close: Jul 19, 2024, 4:00 PM
3.540
-0.120 (-3.28%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
VistaGen Therapeutics Market Cap
VistaGen Therapeutics has a market cap or net worth of $98.91 million as of July 22, 2024. Its market cap has increased by 530.01% in one year.
Market Cap
98.91M
Enterprise Value
-18.13M
1-Year Change
530.01%
Ranking
Category
Stock Price
$3.66
Market Cap Chart
Since May 11, 2016, VistaGen Therapeutics's market cap has increased from $9.30M to $98.91M, an increase of 963.57%. That is a compound annual growth rate of 33.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 98.90M | -28.80% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eledon Pharmaceuticals | 103.97M |
| Oramed Pharmaceuticals | 103.60M |
| Adicet Bio | 101.90M |
| Cardiff Oncology | 100.63M |
| So-Young International | 98.92M |
| Omega Therapeutics | 98.73M |
| Sagimet Biosciences | 98.61M |
| Sensus Healthcare | 98.36M |